Clinical Trials Search Tool

Evaluation of the Lilly SP-X P-tau217 Assay by Measuring Changes in the Intended Patient Management between Pre- and Post-P-tau217 Result: A Randomized Clinical Utility Study

Disease/Condition: Mild Cognitive Impairment and Alzheimer’s Disease

Location: Portland

Ages: 60+

Enrollment Opens: 06-01-2024

Enrollment Closes: TBD

Description:

Seeking participants for a non-interventional clinical trial assessing the clinical usability of the P-tau217 blood sample assay by physicians to assist in diagnosis and treatment plans in a real-life setting.

Study ID: J4Y-MC-B002

To Enroll: Call 503-207-2066

Posted by: Center for Cognitive Health | https://www.centerforcognitivehealth.com/